Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma
暂无分享,去创建一个
J. Yun | W. Jia | Shi‐Mei Zhuang | Yujuan Xiong | Jian-Hong Fang | Jin-E Yang | Ying Zhang
[1] A. Jemal,et al. Global Cancer Statistics , 2011 .
[2] Hong Xu,et al. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. , 2009, Cancer research.
[3] C. Croce,et al. MicroRNAs in Cancer. , 2009, Annual review of medicine.
[4] J. Yun,et al. MicroRNA‐195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells , 2009, Hepatology.
[5] C. Bloomfield,et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.
[6] George A Calin,et al. MicroRNAs and cancer--new paradigms in molecular oncology. , 2009, Current opinion in cell biology.
[7] Benjamin Haibe-Kains,et al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. , 2009, Blood.
[8] A. Bahnassy,et al. Expression of pro‐ and anti‐inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV‐genotype‐4 , 2009, Journal of gastroenterology and hepatology.
[9] Jian-Rong Yang,et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. , 2009, Cancer research.
[10] Jin-Wu Nam,et al. miR-29 miRNAs activate p53 by targeting p85α and CDC42 , 2009, Nature Structural &Molecular Biology.
[11] Rajagopal N. Aravalli,et al. Molecular mechanisms of hepatocellular carcinoma , 2008, Hepatology.
[12] P. Colman,et al. BCL-2 family antagonists for cancer therapy , 2008, Nature Reviews Drug Discovery.
[13] Huating Wang,et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. , 2008, Cancer cell.
[14] Jian-Rong Yang,et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. , 2008, Carcinogenesis.
[15] John Calvin Reed,et al. Bcl-2 family proteins and cancer , 2008, Oncogene.
[16] C. Croce,et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma , 2008, Oncogene.
[17] Nathalie Wong,et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. , 2008, Gastroenterology.
[18] Laura Pelletier,et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.
[19] Kuo-Bin Li,et al. Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target* , 2008, Journal of Biological Chemistry.
[20] Krista A. Zanetti,et al. Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.
[21] Thomas D. Schmittgen,et al. Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.
[22] C. Morrison,et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.
[23] G. Gores,et al. mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.
[24] K. Ghoshal,et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.
[25] C. Croce,et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. , 2007, Cancer research.
[26] T. Tammela,et al. MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.
[27] T. Okanoue,et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.
[28] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Peck-Radosavljevic,et al. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. , 2006, Journal of hepatology.
[30] Y. Pekarsky,et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.
[31] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[32] R. Bataille,et al. Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival , 2005, Leukemia.
[33] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[34] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[35] J. Castle,et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.
[36] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[37] D. Bartel,et al. MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.
[38] R. Russell,et al. bantam Encodes a Developmentally Regulated microRNA that Controls Cell Proliferation and Regulates the Proapoptotic Gene hid in Drosophila , 2003, Cell.
[39] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[40] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.